Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2013 2
2014 3
2015 5
2016 4
2017 3
2019 3
2020 1
2021 4
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJ; ODYSSEY LONG TERM Investigators. Robinson JG, et al. Among authors: lorenzato c. N Engl J Med. 2015 Apr 16;372(16):1489-99. doi: 10.1056/NEJMoa1501031. Epub 2015 Mar 15. N Engl J Med. 2015. PMID: 25773378 Free article. Clinical Trial.
Recent Advances in the Molecular Imaging of Atherosclerosis.
Larivière M, Bonnet S, Lorenzato C, Laroche-Traineau J, Ottonès F, Jacobin-Valat MJ, Clofent-Sanchez G. Larivière M, et al. Among authors: lorenzato c. Semin Thromb Hemost. 2020 Jul;46(5):563-586. doi: 10.1055/s-0039-1701019. Epub 2020 Jun 30. Semin Thromb Hemost. 2020. PMID: 32604420 Review.
Solid Lipid Nanoparticles for Image-Guided Therapy of Atherosclerosis.
Oumzil K, Ramin MA, Lorenzato C, Hémadou A, Laroche J, Jacobin-Valat MJ, Mornet S, Roy CE, Kauss T, Gaudin K, Clofent-Sanchez G, Barthélémy P. Oumzil K, et al. Among authors: lorenzato c. Bioconjug Chem. 2016 Mar 16;27(3):569-75. doi: 10.1021/acs.bioconjchem.5b00590. Epub 2016 Jan 26. Bioconjug Chem. 2016. PMID: 26751997 Free article.
Time between inhibitor detection and start of immune tolerance induction: Association with outcome in the BrazIT study.
Camelo RM, Dias MM, Caram-Deelder C, Gouw S, de Magalhães LP, Zuccherato LW, Jardim LL, de Oliveira AG, de Albuquerque Ribeiro R, Franco VKB, do Rosário Ferraz Roberti M, de Araújo Callado FMR, Etto LY, de Cerqueira MAF, Cerqueira MH, Lorenzato CS, de Souza IS, Serafim ÉSS, Garcia AA, Anegawa TH, Neves DCF, Tan DM, van der Bom J, Rezende SM; Brazilian Immune Tolerance (BrazIT) Study group. Camelo RM, et al. Among authors: lorenzato cs. J Thromb Haemost. 2022 Nov;20(11):2526-2537. doi: 10.1111/jth.15878. Epub 2022 Sep 26. J Thromb Haemost. 2022. PMID: 36102352 Free article.
Changing recombinant factor VIII to plasma-derived factor VIII during immune tolerance induction.
Dias MM, Mesquita Camelo R, de Magalhães LP, Lemos Jardim L, Gonçalves de Oliveira A, Ribeiro RA, Karla Brognoli Franco V, Callado FMRA, Lorenzato CS, Rezende SM; Brazilian Immune Tolerance (BrazIT) Study group. Dias MM, et al. Among authors: lorenzato cs. Pediatr Hematol Oncol. 2024;41(1):74-80. doi: 10.1080/08880018.2023.2182853. Epub 2023 Feb 24. Pediatr Hematol Oncol. 2024. PMID: 36825651 No abstract available.
Multimodal molecular imaging of atherosclerosis: Nanoparticles functionalized with scFv fragments of an anti-αIIbβ3 antibody.
Larivière M, Lorenzato CS, Adumeau L, Bonnet S, Hémadou A, Jacobin-Valat MJ, Noubhani A, Santarelli X, Minder L, Di Primo C, Sanchez S, Mornet S, Laroche-Traineau J, Clofent-Sanchez G. Larivière M, et al. Among authors: lorenzato cs. Nanomedicine. 2019 Nov;22:102082. doi: 10.1016/j.nano.2019.102082. Epub 2019 Aug 9. Nanomedicine. 2019. PMID: 31404651
32 results